6. CLEAN WATER AND SANITATION

Itron, Inc. (NASDAQ:ITRI) CEO Thomas Deitrich Sells 2605 Shares – MarketBeat

Written by Amanda

Itron, Inc. (NASDAQ:ITRI) CEO Thomas Deitrich Sells 2605 Shares  MarketBeat

Itron, Inc. (NASDAQ:ITRIGet Rating) CEO Thomas Deitrich sold 2,605 shares of the company’s stock in a transaction dated Tuesday, September 20th. The shares were sold at an average price of $47.66, for a total transaction of $124,154.30. Following the sale, the chief executive officer now directly owns 146,997 shares of the company’s stock, valued at $7,005,877.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Itron Stock Performance

Shares of ITRI stock traded up $0.23 during trading on Wednesday, reaching $47.08. 6,656 shares of the company’s stock were exchanged, compared to its average volume of 306,438. The company has a quick ratio of 1.26, a current ratio of 1.64 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $2.13 billion, a PE ratio of -21.89 and a beta of 1.29. Itron, Inc. has a twelve month low of $43.18 and a twelve month high of $81.36. The firm’s fifty day moving average price is $51.00 and its 200-day moving average price is $50.03.

Itron (NASDAQ:ITRIGet Rating) last released its earnings results on Thursday, August 4th. The scientific and technical instruments company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.14). Itron had a positive return on equity of 4.45% and a negative net margin of 5.15%. The company had revenue of $431.88 million for the quarter, compared to analyst estimates of $488.53 million. During the same period last year, the company posted $0.28 earnings per share. The business’s revenue for the quarter was down 11.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Itron, Inc. will post 0.77 EPS for the current year.

Institutional Trading of Itron

Several institutional investors and hedge funds have recently modified their holdings of the business. EverSource Wealth Advisors LLC raised its position in Itron by 105.3% in the second quarter. EverSource Wealth Advisors LLC now owns 698 shares of the scientific and technical instruments company’s stock valued at $34,000 after purchasing an additional 358 shares during the last quarter. Wolverine Asset Management LLC bought a new position in shares of Itron during the first quarter worth about $36,000. Nisa Investment Advisors LLC raised its position in shares of Itron by 122.4% during the second quarter. Nisa Investment Advisors LLC now owns 1,090 shares of the scientific and technical instruments company’s stock worth $54,000 after acquiring an additional 600 shares during the last quarter. US Bancorp DE raised its position in shares of Itron by 30.7% during the first quarter. US Bancorp DE now owns 1,040 shares of the scientific and technical instruments company’s stock worth $54,000 after acquiring an additional 244 shares during the last quarter. Finally, Eagle Bay Advisors LLC raised its position in shares of Itron by 106.3% during the second quarter. Eagle Bay Advisors LLC now owns 1,407 shares of the scientific and technical instruments company’s stock worth $70,000 after acquiring an additional 725 shares during the last quarter. 97.36% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. Stephens lowered shares of Itron from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $65.00 to $55.00 in a research report on Friday, August 5th. Cowen reduced their target price on Itron to $68.00 in a research report on Tuesday, August 9th. StockNews.com cut Itron from a “buy” rating to a “hold” rating in a research report on Friday, August 5th. Piper Sandler cut their price objective on Itron from $51.00 to $50.00 and set a “neutral” rating for the company in a report on Tuesday, July 19th. Finally, Morgan Stanley cut their price target on Itron from $60.00 to $55.00 and set an “equal weight” rating for the company in a report on Thursday, June 9th. Eight investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $62.13.

Itron Company Profile

(Get Rating)

Itron, Inc, a technology and service company, provides end-to-end solutions that help manage operations in the energy, water, and smart city space worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.

Featured Stories

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Itron, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Itron wasn’t on the list.

While Itron currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Source: marketbeat.com

About the author

Amanda

Hi there, I am Amanda and I work as an editor at impactinvesting.ai;  if you are interested in my services, please reach me at amanda.impactinvesting.ai

Leave a Comment